Clinical Trials Browser

Terminated × Arthritis, Rheumatoid × Lymphoid × Clear all

NCT02882087 2019-04-03

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Phase 2 Terminated

Arthritis, Rheumatoid, Lymphoma, Follicular